The positive influence of pembrolizumab monotherapy compared with toxic chemotherapy in MSI-H GC patients with programmed cell death-ligand 1 (PD-L1) has been reported in KEYNOTE-062 and KEYNOTE-177 studies17,18. The gene discussed is CD274; the disease is gastric cancer.